OBJECTIVES: We sought to update our meta-analysis on clinical outcomes with aspiration thrombectomy prior to primary percutaneous coronary intervention (PPCI) compared with conventional PPCI alone due to the availability of additional trial data. BACKGROUND: The clinical efficacy of adjunctive aspiration thrombectomy in ST-elevation myocardial infarction (STEMI) patients undergoing PPCI remains controversial. A recent large-scale randomized trial showed no benefit in terms of mortality at 30 days. METHODS: Clinical trials that randomized STEMI patients to aspiration thrombectomy prior to PPCI compared with conventional PPCI alone were included. RESULTS: A total of 11,321 patients from 20 randomized controlled trials were included. The composite major adverse cardiac event (MACE) endpoint was lower in the aspiration thrombectomy arm compared with conventional PPCI alone (risk ratio [RR] = 0.81, 95% CI 0.70-0.94; P = 0.006). Although all-cause mortality was similar between the adjunctive aspiration thrombectomy arm and PPCI arms (RR = 0.83, 95% CI 0.67-1.01; P = 0.06), late mortality (6-12 months) was significantly reduced (RR = 0.64; 95% CI 0.44-0.92; P = 0.016). Reinfarction (RR = 0.64, 95% CI 0.44-0.92; P = 0.017) and stent thrombosis (RR = 0.54; 95% CI 0.32-0.91; P = 0.021) were similarly lower. Differences in target vessel revascularization were of borderline significance (RR = 0.83, 95% CI 0.68-1.01; P = 0.06). CONCLUSIONS: Our meta-analysis including all randomized controlled trials on aspiration thrombectomy to date demonstrates a significant reduction in adverse clinical outcomes including stent thrombosis compared with conventional PCI alone.
OBJECTIVES: We sought to update our meta-analysis on clinical outcomes with aspiration thrombectomy prior to primary percutaneous coronary intervention (PPCI) compared with conventional PPCI alone due to the availability of additional trial data. BACKGROUND: The clinical efficacy of adjunctive aspiration thrombectomy in ST-elevation myocardial infarction (STEMI) patients undergoing PPCI remains controversial. A recent large-scale randomized trial showed no benefit in terms of mortality at 30 days. METHODS: Clinical trials that randomized STEMI patients to aspiration thrombectomy prior to PPCI compared with conventional PPCI alone were included. RESULTS: A total of 11,321 patients from 20 randomized controlled trials were included. The composite major adverse cardiac event (MACE) endpoint was lower in the aspiration thrombectomy arm compared with conventional PPCI alone (risk ratio [RR] = 0.81, 95% CI 0.70-0.94; P = 0.006). Although all-cause mortality was similar between the adjunctive aspiration thrombectomy arm and PPCI arms (RR = 0.83, 95% CI 0.67-1.01; P = 0.06), late mortality (6-12 months) was significantly reduced (RR = 0.64; 95% CI 0.44-0.92; P = 0.016). Reinfarction (RR = 0.64, 95% CI 0.44-0.92; P = 0.017) and stent thrombosis (RR = 0.54; 95% CI 0.32-0.91; P = 0.021) were similarly lower. Differences in target vessel revascularization were of borderline significance (RR = 0.83, 95% CI 0.68-1.01; P = 0.06). CONCLUSIONS: Our meta-analysis including all randomized controlled trials on aspiration thrombectomy to date demonstrates a significant reduction in adverse clinical outcomes including stent thrombosis compared with conventional PCI alone.
Authors: Johannes Blumenstein; Steffen Daniel Kriechbaum; Jürgen Leick; Alexander Meyer; Won-Keun Kim; Jan Sebastian Wolter; Maisun Abu-Samra; Kay Weipert; Matthias Bayer; Oliver Dörr; Claudia Walther; Christian W Hamm; Holger Nef; Christoph Liebetrau; Helge Möllmann Journal: J Thromb Thrombolysis Date: 2018-02 Impact factor: 2.300
Authors: Sanjit S Jolly; John A Cairns; Salim Yusuf; Brandi Meeks; Janice Pogue; Michael J Rokoss; Sasko Kedev; Lehana Thabane; Goran Stankovic; Raul Moreno; Anthony Gershlick; Saqib Chowdhary; Shahar Lavi; Kari Niemelä; Philippe Gabriel Steg; Ivo Bernat; Yawei Xu; Warren J Cantor; Christopher B Overgaard; Christoph K Naber; Asim N Cheema; Robert C Welsh; Olivier F Bertrand; Alvaro Avezum; Ravinay Bhindi; Samir Pancholy; Sunil V Rao; Madhu K Natarajan; Jurriën M ten Berg; Olga Shestakovska; Peggy Gao; Petr Widimsky; Vladimír Džavík Journal: N Engl J Med Date: 2015-03-16 Impact factor: 91.245
Authors: Diego Fernández-Rodríguez; Luis Alvarez-Contreras; Victoria Martín-Yuste; Salvatore Brugaletta; Ignacio Ferreira; Marta De Antonio; Montserrat Cardona; Vicens Martí; Juan García-Picart; Manel Sabaté Journal: World J Cardiol Date: 2014-09-26
Authors: Regina El Dib; Frederick Alan Spencer; Erica Aranha Suzumura; Huda Gomaa; Joey Kwong; Gordon Henry Guyatt; Per Olav Vandvik Journal: BMC Cardiovasc Disord Date: 2016-06-02 Impact factor: 2.298
Authors: Alberto Dominguez-Rodriguez; Pedro Abreu-Gonzalez; Luciano Consuegra-Sanchez; Pablo Avanzas; Alejandro Sanchez-Grande; Pablo Conesa-Zamora Journal: Int J Med Sci Date: 2016-06-18 Impact factor: 3.738